March isn’t quite over as we write this, and neither is the madness—which won’t stop us from posting the biggest deals of the month. As of Friday, March 27, $34.4 billion has been committed to finance about 105 transactions. Of course, $21 billion of that comes from the AbbVie (NYSE: ABBV) acquisition of Pharmacyclics (NASDAQ: PCYC). Next week, preliminary Q1:15 results!
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
